Geisinger, along with two university partners, has been awarded an $8.5 million, five-year grant from the National Institutes of Health (NIH) to study the role of genetics in neuropsychiatric disorders, including autism spectrum disorder, schizophrenia, and bipolar disorder. Geisinger was awarded the grant with the University of Washington in Seattle and Washington University in St. Louis. The project is one of five funded as part of the newly established Mental Health Rare Genetic Disease Network (MHRGDN), which includes researchers at 15 sites across the United States. Researchers from the 15 sites will recruit patients with known genetic causes of neuropsychiatric disorders. They will then conduct in-depth genomic and clinical assessments of patients and their family members to explore the impact of genetics on neuropsychiatric disorders. The standardized data will be made available to research facilities throughout the country to accelerate further research.